Back to Continuing Education

Want to buy for someone else? You can purchase a token at check out.

Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
This module provides healthcare professionals with information on the rising incidence of three life-threatening endemic fungal diseases in the U.S.
Goals and Outcomes
Goals and Learning Outcomes
Coccidioidomycosis, histoplasmosis and blastomycosis - caused respectively by Coccidioides immitis, Histoplasma capsulatum and Blastomyces dermatitidis - are endemic mycoses, or fungal diseases, that have emerged as important health threats for people who live or travel in certain regions of the U.S. Each disease is caused by a dimorphic fungus, which is a fungus that grows as a mold with septate hyphae (threadlike filaments divided by cross walls into sections) in the soil, and as a yeast cell or spherule in the human body. People acquire these diseases almost exclusively by inhaling the pathogens in their mold phase from dust in the environment. Endemic fungi are capable of causing infections in both healthy and immunocompromised people. This module provides healthcare professionals of various disciplines with information on the rising incidence of three life-threatening endemic fungal diseases in the U.S.

After taking this course, you should be able to:

  • Name three endemic fungi of medical importance in the U.S. and describe their geographic distribution
  • Describe the three diseases associated with dimorphic fungi
  • Explain why endemic fungal diseases are difficult to diagnose and treat

Course Termination Date: 12/31/23

Content Expiration Date: 03/31/22

Course Originally Released On: 05/01/19
Details
Course Details

Course Originally Released on : 5/1/2019

REL-ACU-0-CE597

Course Author

Dawn Demangone-Yoon

MD

Connie C. Chettle

MS, MPH, RN

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.